Reneural Technologies raises £475k in pre-seed investment and grant funding led by SFC Capital
The funding round was led by SFC Capital with additional support from Innovate UK.
Reneural Technologies is a neurotech company developing a platform to support stroke survivors with rehabilitation and mental health care. The company aims to improve patient outcomes and reduce the burden on clinicians through remote care technologies.
Reneural Technologies has raised £475k in a pre-seed funding and grant round led by SFC Capital, alongside undisclosed backers and Innovate UK. The capital will be directed towards developing virtual reality therapy offerings and expanding into mental health support for stroke survivors.
The investment coincides with participation in Innovate UK's Investor Partnerships SME Round 7. The company previously secured early support from Innovate UK in 2022 to build initial proof of concept work for its platform.
From the founder
"We are excited to have such an incredible group of investors supporting our mission to leverage technology in transforming healthcare delivery, improving access, quality, and efficiency for both patients and clinicians."
Victor Harabari
CEO at Reneural Technologies
Investor perspective
"We’re excited to have led the investment into Reneural and to support the team on their journey to improve rehabilitation for stroke survivors. What really impressed us was their passion for tackling this problem, and we’re looking forward to seeing their impact on patient outcomes through their new VR products and mental health support."
Ed Stevenson
Principal, SFC Capital
Use of funds
- 01Continue product development
- 02Fund research and development
Investors
Categories
About the company
Reneural Technologies
Reneural Technologies provides a neurorehabilitation platform for stroke survivors using virtual reality and other advanced technologies.